The use of automated contrast injector systems during percutaneous coronary intervention (PCI) does not appear to curb kidney damage compared with manual injection, according to an analysis published ...
The FDA has granted expanded indications for use of gadobutrol (Gadavist; Bayer) injection, permitting its use in cardiac MR to assess myocardial perfusion and late gadolinium enhancement in adults ...
Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington and presented at the 2022 Radiological Society of North America (RSNA) Congress, ...
The US Food and Drug Administration (FDA) has granted expanded clearance to Bayer’s Medrad MRXperion, broadening the magnetic resonance (MR) injection system’s application across a wider range of MRI ...
Designed for contrast media injections, the PowrSyringe is capable of an injection that is between 20 and 100% faster than a standard control syringe. Nothing beats the need for speed when it comes to ...
Global Contrast Injector Market report has a chapter on the global market and all its associated companies with their profiles, which provides valuable data related to their outlook in terms of ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...
Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results